JPRN-jRCT1080221871未知4 期
A double-blind, parallel group, comparative study of coadministration AD-4833 and SYR-322
TAKEDA PHARMACEUTICAL COMPANY LTD.0 个研究点开始时间: 2012年7月30日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Those judged to be capable of understanding and complying with protocol requirements by the investigator or subinvestigator.
- •Those who can sign and date a written, informed consent form prior to the initiation of any study procedures.
排除标准
- •Those with concurrent serious cardiac disease, serious cerebrovascular disorder, or serious pancreatic or hematological disease etc.
- •Others who are assessed to be ineligible for the study by the investigator or subinvestigator.
研究者
相似试验
未知
3 期
A Double-Blind, Parallel Group, Comparative Study of Intravenous S-021812 in Patients with Influenza Virus Infectioinfluenza virus infectionJPRN-jRCT2080220735SHIONOGI & CO., LTD.
已完成
2 期
Double-Blind, parallel-group comparison, investigators initiated phase II clinical trial of IDEC-C2B8 (Rituximab) in patients with Systemic Sclerosissystemic sclerosisJPRN-UMIN000030139The University of Tokyo Hospital56
已完成
不适用
A randomised, double-blind, parallel-group comparison of the efficacy and the safety of venlafaxine versus nortriptyline in the treatment of depressed elderly inpatientsDepressive disordersMental and Behavioural DisordersDepressionISRCTN23246262Altrecht GGZ (The Netherlands)81
已完成
不适用
To check the efficacy of cosmetic products in offering protection against skin stress inducers including pollutioCTRI/2021/02/031335ITC Limited ITC Life Sciences Technology Center98
招募中
2 期
GP-01 gel for the treatment of PsoriasisCTRI/2021/08/035763utrin GmbH